Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kirsti Svendsen Andersson"'
Autor:
Vivian M Dalaker, Kirsti Svendsen Andersson, Knut Erik Hovda, Linn Elisabeth Fosshaug, Odd Martin Vallersnes
Publikováno v:
Tidsskrift for Den norske legeforening. 135:2067-2070
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::476242e06cdf20a023859c0fef73341c
https://doi.org/10.4045/tidsskr.15.0190
https://doi.org/10.4045/tidsskr.15.0190
Publikováno v:
Clinical Toxicology. 43:221-227
Methanol is metabolized by alcohol dehydrogenase to formaldehyde, and further to formic acid, which is responsible for the toxicity in methanol poisoning. Fomepizole (4-methylpyrazole) is a potent competitive inhibitor of alcohol dehydrogenase and is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03b5590e25cbbf713b922d788e0add6
https://doi.org/10.1081/clt-200058936
https://doi.org/10.1081/clt-200058936
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 127(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47cf765f46d58e6a1c48dbac56d99157
https://pubmed.ncbi.nlm.nih.gov/17571108
https://pubmed.ncbi.nlm.nih.gov/17571108
Publikováno v:
Pharmacotherapy. 27(4)
Two men, aged 83 and 78 years, who received stable therapy with simvastatin 80 mg/day were hospitalized 1-2 weeks after completion of short-term treatment with erythromycin and clarithromycin, respectively. Both patients were admitted with myalgia, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a51c3ec77117202d4b1ad046800e667
https://pubmed.ncbi.nlm.nih.gov/17381388
https://pubmed.ncbi.nlm.nih.gov/17381388
Autor:
John F. Stover, Kirsti Svendsen Andersson, Julia Hasslacher, Reto Stocker, Sarah Brett, Detlef Kindgen-Milles, Harm Peters, Torsten Slowinski, Justyna Kozik-Jaromin, Michael Joannidis, Thomas Henneberg, Stanislao Morgera, Markus Wehner, Elin Helset, Hans-H. Neumayer
Publikováno v:
Critical Care
Introduction Regional citrate anticoagulation (RCA) for continuous renal replacement therapy is widely used in intensive care units (ICUs). However, concern exists about the safety of citrate in patients with liver failure (LF). The aim of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e1c7442553d8ee7ae0c0ef5244f6eec